Report Highlights
The global market for MRI systems reached $5.8 billion in 2015. The market should reach nearly $6.1 billion and $8.0 billion in 2016 and 2021 respectively, growing at a compound annual growth rate (CAGR) of 5.7% from 2016 to 2021.
Report Includes
- An overview of the global markets and technologies for medical magnetic resonance imaging (MRI).
- Analyses of market trends, with data from 2015, 2016, and projections of compound annual growth rates (CAGRs) through 2021.
- Descriptions of the trends and developments for each type of MRI technology and how each is meant to satisfy the needs of customers.
- Identification of highly competitive MRI industries and their position in the overall imaging market.
- A look at macro trends that benefit the MRI market, which include:
- A globally aging population.
- Continued global urbanization.
- Prevalence of major diseases such as heart disease, cancer and diabetes.
- Expanding access to health-care products and services, particularly in rural areas and for younger populations.
- Examination of the MRI business in terms of specific companies and their position in the market.
- Profiles of major players in the industy.
SCOPE OF REPORT
The report includes only those devices and products that are listed above. It segments the global market and the products market only by four regions as listed above. The scope of the report includes and covers the following:
- Key market segment analysis.
- Market dynamics (drivers and restraints).
- Market estimation for the forecast period of 2016 through 2021.
- Competitive developments and landscape.
- Regional analysis.
- Profiles of key market players.
- Patents.
Analyst Credentials
Himani Singhi has been working in healthcare, biotechnology and life sciences business research and consulting since 2009. She has expertise in business strategy, market and competitive intelligence, business performance measurement and management, business analysis and analytics, and forecasting. Himani studied in the U.K. and holds double masters, one in life sciences/allied science and the other in business analysis.
Report Highlights
The global market for MRI systems was $4.9 billion in 2012. This market is projected to reach $5.4 billion in 2013 and $6.9 billion by 2018, at an estimated compound annual growth rate (CAGR) of 5% from 2013 to 2018.
Report Includes
- Descriptions of the trends and developments for each type of MRI technology and how each is meant to satisfy the needs of customers.
- Analyses of market trends, with data from 2012, estimates for 2013 and projections of compound annual growth rates (CAGRs) through 2018.
- Examination of the MRI business in terms of specific companies and their position in the market.
- Identification of highly competitive MRI industries and their position in the overall imaging market.
Report Highlights
-
In the U.S., recent reimbursement changes and the economic downturn have called the expanding use of MRI scanning into question. The North American market is worth $2.3 billion in 2010 and is expected to increase at a 4.4% compound annual growth rate (CAGR) to reach $2.9 billion in 2015.
-
Europe ranks with the U.S. as one of the most developed MRI markets. Expanding applications in the neurologic, cardiac, and breast MRI areas should drive the EU market. This sector is estimated at $1.2 billion in 2010 and is expected to increase at a 10% compound annual growth rate (CAGR) to reach $1.9 billion in 2015.
-
Japan remains an early adopter of newer MRI equipment, making it a prime opportunity for newer 3T equipment. This market is valued at $1 billion in 2010 and should reach $1.3 billion in 2015, a compound annual growth rate (CAGR) of 4.3%.
Related Reports
Fluoroscopy and C-arms: Technologies and Global Markets
The global market for fluoroscopy and C-arms reached $2.2 billion in 2017 and should reach nearly $2.7 billion in 2022 at a compound annual growth rate (CAGR) of 3.8% for the period of 2017-2022.
Biologic and Medical Imaging Reagents: Global Markets
The global market for biological imaging reagents was valued at $13.2 billion in 2016. This market will grow from $14.4 billion in 2017 to nearly $23.9 billion by 2022 with a compound annual growth rate (CAGR) of 10.6% for the period of 2017-2022.
Thick Film Devices, Processes and Applications
The global market for thick film devices increased from $56.8 billion in 2015 to $60.8 billion in 2016. This market is estimated to reach $110.3 billion in 2022 from $66.5 billion in 2017 at a compound annual growth rate (CAGR) of 10.6% for 2017-2022.
Biologic Imaging Reagents: Technologies and Global Markets
The global market for biologic imaging reagents was valued at $9.4 billion in 2011 and is expected to reach $9.9 billion in 2012. Total market value is expected to reach nearly $14.5 billion in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 7.8%.
Recent Reports
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
Infusion Pumps and Devices: Technologies and Global Markets
The global market for infusion pumps is expected to grow from $10.1 billion in 2024 and is projected to reach $14.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.7% during the forecast period of 2024 to 2029.
Top Trending Reports
AI in Clinical and Molecular Diagnostics Market
The global market for AI in clinical and molecular diagnostics is expected to grow from $2.6 billion in 2024 and is projected to reach $8.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.6% during the forecast period of 2024 to 2029.
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Artificial Intelligence (AI) Market: Investments vs Potential
The global market for artificial intelligence (AI) is estimated to increase from $148.8 billion in 2023 to reach $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 39.7% from 2024 through 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More